VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SRTA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SRTAStrata Critical Medical, Inc.
$5.24$453M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSRTAQuarterly Financials

Strata Critical Medical, Inc. (SRTA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Strata Critical Medical, Inc. (SRTA) quarterly income statement — complete revenue, gross profit & net income history

SRTA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue67.38M22.74M49.3M70.8M54.31M54.36M74.88M67.94M51.51M47.48M71.44M60.99M45.27M38.13M45.72M35.63M26.63M24.62M20.32M12.95M
Revenue Growth %24.08%-58.17%-34.16%4.2%5.42%14.49%4.81%11.41%13.79%24.5%56.25%71.16%70%54.91%125.05%175.14%-208.26%144.21%276.7%
Cost of Goods Sold53.27M22.94M37.68M53.06M42.33M41.77M55.04M51.59M41.38M38.47M55.86M50.62M38.11M33.16M36.46M30.52M23.71M20.64M15.82M9.91M
COGS % of Revenue79.05%100.89%76.44%74.95%77.94%76.84%73.51%75.93%80.32%81.02%78.19%83%84.18%86.95%79.73%85.66%89.02%83.83%77.85%76.52%
Gross Profit14.12M-203K11.61M17.74M11.98M12.59M19.84M16.35M10.14M9.01M15.58M10.37M7.16M4.97M9.27M5.11M2.92M3.98M4.5M3.04M
Gross Margin %20.95%-0.89%23.56%25.05%22.06%23.16%26.49%24.07%19.68%18.98%21.81%17%15.82%13.05%20.27%14.34%10.98%16.17%22.15%23.48%
Gross Profit Growth %17.86%-101.61%-41.45%8.46%18.14%39.72%27.33%57.72%41.53%81.11%68.13%102.88%145.09%25%105.91%68.07%-145.83%180.55%379.65%
Operating Expenses17.09M3.99M17.24M22.69M19.56M20.96M23.37M28.5M20.01M44.64M23.03M22.58M19.99M24.65M19.69M14.84M16.61M14.52M14.23M10.81M
OpEx % of Revenue25.36%17.55%34.96%32.05%36.02%38.56%31.22%41.95%38.84%94.03%32.23%37.02%44.16%64.65%43.07%41.66%62.38%58.97%70.04%83.48%
Selling, General & Admin15.61M19.34M16.78M21.78M18.75M20.22M22.57M27.53M19.34M43.66M21.95M21.14M18.87M23.03M17.67M13.78M15.78M13.87M13.27M10.6M
SG&A % of Revenue23.16%85.07%34.04%30.76%34.52%37.19%30.15%40.52%37.54%91.95%30.73%34.66%41.68%60.39%38.64%38.68%59.25%56.33%65.32%81.84%
Research & Development01.7M453K915K812K743K800K971K670K988K1.08M1.44M1.12M1.62M2.03M1.06M835K649K959K213K
R&D % of Revenue-7.47%0.92%1.29%1.5%1.37%1.07%1.43%1.3%2.08%1.51%2.36%2.48%4.25%4.43%2.98%3.14%2.64%4.72%1.64%
Other Operating Expenses1000K-1000K000000000000000000
Operating Income-2.97M-4.19M-5.62M-4.95M-7.58M-8.37M-3.54M-12.15M-9.87M-35.63M-7.45M-12.21M-12.83M-19.68M-10.43M-9.73M-13.69M-10.54M-9.73M-7.77M
Operating Margin %-4.41%-18.45%-11.4%-7%-13.96%-15.4%-4.72%-17.88%-19.16%-75.05%-10.43%-20.02%-28.33%-51.6%-22.81%-27.31%-51.41%-42.8%-47.89%-60%
Operating Income Growth %60.78%49.9%-58.95%59.22%23.16%76.5%52.51%0.49%23.07%-81.08%28.58%-25.44%6.3%-86.77%-7.18%-25.25%-5722.73%-344.93%-1230.92%-426.49%
EBITDA-2.97M-1.19M-3.92M-3.18M-5.89M-6.84M-2.26M-10.59M-8.27M-33.83M-5.61M-10.4M-11.66M-19.59M-9.05M-26.27M-14.96M-9.82M-9.54M-7.77M
EBITDA Margin %-4.41%-5.22%-7.95%-4.49%-10.84%-12.59%-3.02%-15.59%-16.06%-71.25%-7.85%-17.05%-25.76%-51.36%-19.8%-73.72%-56.17%-39.89%-46.95%-60%
EBITDA Growth %49.47%82.67%-73.52%69.99%28.86%79.77%59.71%-1.84%29.04%-72.7%38.09%60.41%22.05%-99.48%5.08%-238.03%-6262.47%-340.51%-1481.76%-478.63%
D&A (Non-Cash Add-back)03.01M1.7M1.78M1.7M1.53M1.28M1.56M1.59M1.81M1.84M1.81M1.17M91K1.38M-16.54M-1.27M717K191K0
EBIT-2.97M-3.18M-5.62M-4.95M-7.58M-8.37M-3.54M-12.15M-9.87M-34.96M-7.45M-12.21M-12.83M-19.68M-10.43M-9.73M-13.69M-10.54M-9.73M-7.77M
Net Interest Income0638K1.13M1.16M1.32M1.59M1.76M1.79M2.07M2.26M2.15M01.95M1.54M1.17M455K0290K222.39K0
Interest Income0638K1.13M1.16M1.32M1.59M1.76M1.79M2.07M2.26M2.15M01.95M1.54M1.17M455K264K290K309K0
Interest Expense0000000000000000264K086.61K0
Other Income/Expense5.38M1.02M-4.04M1.23M4.07M-1.53M1.47M875K5.55M669K7.87M-399K2.44M3.44M1.24M18.14M2.68M11.2M-3.1M-16.52M
Pretax Income2.4M-3.18M-9.66M-3.72M-3.51M-9.9M-2.07M-11.27M-4.32M-34.96M418K-12.61M-10.39M-16.24M-9.19M8.41M-11.01M663K-12.83M-24.29M
Pretax Margin %3.56%-13.97%-19.59%-5.26%-6.46%-18.21%-2.77%-16.59%-8.38%-73.64%0.59%-20.67%-22.95%-42.59%-20.1%23.61%-41.35%2.69%-63.14%-187.52%
Income Tax248K3.44M021K-17K-105K-118K52K-84K-1.02M129K-376K-196K-828K56K264K-264K-109K-3.64M0
Effective Tax Rate %10.32%-108.44%0%-0.56%0.48%1.06%5.69%-0.46%1.95%2.93%30.86%2.98%1.89%5.1%-0.61%3.14%2.4%-16.44%28.4%0%
Net Income2.15M-8.83M57.42M-3.74M-3.49M-9.79M-1.95M-11.33M-4.23M-33.94M289K-12.23M-10.19M-15.41M-9.24M8.15M-10.75M772K-9.18M-24.29M
Net Margin %3.2%-38.85%116.47%-5.29%-6.43%-18.02%-2.61%-16.67%-8.22%-71.49%0.4%-20.06%-22.51%-40.42%-20.22%22.87%-40.36%3.14%-45.21%-187.52%
Net Income Growth %161.67%9.8%3038.38%66.95%17.5%71.15%-776.12%7.41%58.46%-120.18%103.13%-250.12%5.17%-2096.76%-0.66%133.55%-894.28%132.7%-1188.08%-1732.91%
Net Income (Continuing)2.15M-5.39M-9.66M-3.74M-3.49M-9.79M-1.95M-11.33M-4.23M-33.94M289K-12.23M-10.19M-15.41M-9.24M8.15M-10.75M772K-9.18M-24.29M
Discontinued Operations0-1000K1000K00000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.03-0.11-0.04-0.05-0.04-0.12-0.03-0.15-0.06-0.450.00-0.17-0.14-0.22-0.130.12-0.150.01-0.13-0.33
EPS Growth %175%8.33%-46.4%69.33%28.44%73.33%-11.76%60.07%-104.55%102.54%-241.67%6.67%-2300%0%136.36%-145.9%117.3%-965.57%-
EPS (Basic)0.03-0.11-0.04-0.05-0.04-0.12-0.03-0.15-0.06-0.450.00-0.17-0.14-0.22-0.130.12-0.150.01-0.13-0.47
Diluted Shares Outstanding90.17M82.45M82.45M81.3M79.89M79.42M78.04M78.04M75.8M74.66M81.01M73.17M71.99M71.66M71.47M71.47M70.77M77.68M70.1M73.45M
Basic Shares Outstanding85.32M82.45M82.45M81.3M79.89M79.42M78.04M78.04M75.8M74.66M74.14M71.95M71.99M71.65M71.12M71.12M68.83M69.76M69.01M51.57M
Dividend Payout Ratio--------------------